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Abstract
A growing body of evidence suggests that the risk of development and progression of a variety of human chronic
diseases depends on epigenetic modifications triggered by environmental cues during early life sensitive stages.
Exposures to environmental factors such as adverse nutritional, psychological, and social conditions, as well as pollutants
and substance abuse in early life, have been shown to be important determinants of epigenetic programming of
chronic pathological conditions in human populations. Over the past years, it has become increasingly clear due to the
epigenome-wide association studies (EWASs) that early life adverse environmental events may trigger widespread and
persistent alterations in transcriptional profiling. Several candidate genes have been identified underlying these
associations. In this context, DNA methylation is the most intensively studied epigenetic phenomenon. In this review,
the clinical and epidemiological evidence for the role of epigenetic factors in mediating the link between early life
experiences and long-term health outcomes are summarized.
Keywords: Developmental programming, Chronic disease, Epigenetic modification, DNA methylation,
Environmental xenobiotic, Nutrition, Stress
Introduction
During the past decades, the burden of chronic diseases is
rapidly increasing worldwide. Adult lifestyle factors are
the main risk contributors. It is, however, increasingly
clear that unfavorable events during early development
may also play a crucial role in the pathogenesis of chronic
pathological conditions. The Developmental Origins of
Health and Disease concept suggests that adverse ex-
posures early in life may reprogram an individual for
immediate adaptation to prenatal and/or neonatal envir-
onmental perturbations but enhance the risk of subse-
quent pathologies including cancer, type 2 diabetes (T2D),
cardiovascular (CVD), and neurodegenerative disease [1].
The mechanisms implicated in developmental program-
ming of chronic disorders are poorly understood, but epi-
genetic mechanisms are likely involved. In mammals, the
epigenome undergoes major epigenetic modifications
throughout the gametogenesis and early embryogenesis
[2, 3]. In the early embryo, a dramatic reduction in me-
thylation takes place; the methylation levels reach their
minimum at the early blastocyst stage (32–64 cells). This
process of epigenetic reprogramming throughout early
embryogenesis erases gamete-specific methylation pat-
terns inherited from the parents and is crucial to
establishing pluripotency. After implantation, a wave of
de novo methylation occurs. Another demethylation–
remethylation cycle of epigenetic reprogramming takes
place in the primordial germ cells which are the embry-
onic progenitors of oocytes and sperm. However, these
processes differ in primordial germ cells and in embryos.
In primordial germ cells, demethylation is close to abso-
lute (with the exception of a few resistant retroelements),
whereas in early embryos, methylation of imprinted gene
regions is preserved, enabling parent-of-origin-specific
gene expression in later tissues [2]. Early embryonic main-
tenance is especially critical in the context of develop-
mental programming because this process is sensitive toCorrespondence: vaiserman23@gmail.com
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environmental cues [3]. The epigenetic modifications trig-
gered by environmental stimuli during these sensitive pe-
riods can persist across the life course thereby leading to
pathological conditions in adulthood [4]. The role of epi-
genetic regulators in linking adverse early events to later
outcomes is evident from both epigenome-wide associ-
ation studies (EWASs) and studies of particular candidate
genes.
Most data concerning developmental epigenetic pro-
gramming of various pathologies have been obtained from
animal models. Human findings confirming the importance
of epigenetic mechanisms in such programming effects are
still scarce because of limited access to relevant biological
materials, but they evidently indicate that similar mecha-
nisms may also operate in humans. This review summa-
rizes the clinical and epidemiological evidence for the role
of epigenetic factors in mediating the link between early life
experiences and long-term health outcomes.
Review
Environmental xenobiotics
Exposure to environmental xenobiotics is among the
major causes of chronic health problems in modern so-
ciety. The period from preconception through weaning
is likely a key time window when such exposure can
harm human development [3]. During pregnancy, the
environmental pollutants can cross the placenta, leading
to distorted gene expression patterns and disease patho-
genesis in later life [5]. Pollutants also may accumulate
in breast milk to levels causing subsequent health prob-
lems, so lactation period is apparently important as well.
Air pollution
Early life exposure to air pollution has been repeatedly
shown to affect the risk of various allergic complications
in subsequent life. Epigenetic modifications which are
associated with inflammation and immunity are believed
to be key contributors to the link between exposure to air
pollution and later allergy-related conditions. In utero
exposure to higher levels of traffic-related polycyclic aro-
matic hydrocarbons (PAHs) has been found to be associ-
ated with aberrant DNA methylation, thereby resulting in
childhood asthma. For example, hypermethylation of the
acyl-CoA synthetase long-chain family member 3 (ACSL3)
gene implicated in asthma pathogenesis has been indi-
cated in umbilical cord white blood cells of neonates who
were prenatally exposed to PAHs [6].
Endocrine-disrupting chemicals
There is a growing concern among scholars and public
health officials about the risks associated with human
exposure to endocrine-disrupting chemicals (EDCs), the
substances which exhibit the hormone-like activity. Cur-
rently, EDCs including agricultural pesticides, dioxin,
phthalates, industrial solvents, and polychlorinated bi-
phenyls are widespread in the modern human environ-
ments [7, 8]. There is increasing evidence suggesting
that early life exposure to EDCs may cause long-term
health outcomes and that epigenetic mechanisms may
be substantially involved. Most of these findings are de-
rived from animal studies (for review, see [9]). Human
data confirming these associations are scarce to date.
The most studied EDC in the epigenetic context is
bisphenol A (BPA), a carbon-based synthetic compound
with estrogenic activity which is widely used in the manu-
facture of polycarbonate plastics and epoxy resins. There
is increasing evidence that exposure to BPA in early life
can promote various diseases, including infertility, meta-
bolic disorders, and several hormone-associated tumors
such as prostate and breast cancers [10]. BPA-induced
alterations in the methylation of gene-coding xenobiotic
metabolizing enzymes such as increased methylation at
catechol-O-methyltransferase (COMT) and at sulfotrans-
ferase 2A1 (SULT2A1) promoters in human fetal liver
have been revealed [11]. More recently, the global DNA
methylation and expression of gene-coding metabolizing
enzymes have been characterized in human fetal tissues,
namely, placenta, kidney, and liver, after prenatal BPA ex-
posure [12]. The significant tissue-specific DNA methyla-
tion differences in both long interspersed nucleotide
element-1 (LINE-1) and CCGG content have been ob-
served. Total BPA concentrations have been positively
correlated with global methylation levels for the placenta
only using the LINE-1 assay. Expression levels of the BPA-
specific metabolism genes including lysosomal enzyme
beta-glucuronidase (GUSB), UDP glucuronosyltransferase
2 family, polypeptide B15 (UGT2B15), steroid sulfatase
(microsomal), isozyme S (STS), and SULT1A1 have been
different across each tissue type.
Heavy metals
Heavy metals including cadmium, mercury, lead, and
arsenic are another important class of pollutants in
modern environments [13]. Prenatal exposure to heavy
metals is especially detrimental. It has been found to be
a risk factor for neurological disorders and several can-
cers. These adverse outcomes are thought to be medi-
ated by epigenetic changes that persist over time and
affect long-term health conditions [14].
The genome-wide changes in DNA methylation caused
by prenatal exposure to cadmium have been found [15]. In
girls, overrepresentation of methylation changes in genes
related to organ development, mineralization, and morph-
ology of bone has been obtained, while in boys, the alter-
ations in cell-death-linked genes have been demonstrated.
In another methylome-wide association study (MWAS),
prenatal cadmium exposure resulted in changed patterns
of DNA methylation in leukocytes, with enrichment of
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genes involved in apoptosis and transcriptional regulation
[16]. Periconceptional cadmium exposure has been also as-
sociated with hypomethylation of LINE-1, which is highly
methylated in normal tissues, whereas its hypomethylation
is known to cause enhanced genomic instability [17].
In some studies, DNA methylation levels in cord blood
DNA of newborns have been shown to be associated
with prenatal arsenic exposure [18–23]. The correlation
between levels of methylation of repetitive elements such
as LINE-1 and Arthrobacter luteus (Alu, short inter-
spersed nucleotide element), which are able to mutate
other genes via their mobility, and levels of prenatal ar-
senic exposure has been positive among male infants but
negative among female infants [19]. Mother’s urinary
levels of arsenic, mostly during early pregnancy, have
been associated with cord blood DNA methylation in
neonates [20]. Overrepresentation of affected cancer-
related genes in boys, but not in girls, has been revealed.
Much weaker associations have been demonstrated with
arsenic exposure in late compared to early gestation.
The activation of molecular networks that are indicative
of stress, inflammation, metal exposure, and apoptosis
has been revealed in newborns whose mothers expe-
rienced arsenic exposure throughout pregnancy [21]. A
positive correlation between methylation levels of par-
ticular loci in CpG islands in cord blood samples of
infants and a mother’s urinary arsenic levels has been
obtained in the Koestler et al. [22] study. Genes that
demonstrated significant differences in DNA methyla-
tion after the prenatal arsenic exposure have been highly
enriched for binding sites of the transcription factors
such as early growth response and CCCTC-binding fac-
tors [23]. Prenatal arsenic exposure has been also associ-
ated with changes in expression of the soluble fms-like
tyrosine kinase-1 (sFLT1) gene playing a key role in the
inhibition of placental angiogenesis and related growth
retardation in cord blood cells [24].
In a recent MWAS, association between DNA methy-
lation in newborn cord blood and prenatal mercury con-
centrations has been revealed suggesting that exposure
to mercury may lead to epigenetic modifications in-
volved in altered immune profiles [14]. Prenatal mercury
exposure has been associated with placental DNA me-
thylation changes and adverse infant neurobehavioral
outcomes in the Maccani et al. study [25]. Lead levels in
maternal tissues such as patella and tibia have been shown
to be inversely correlated with levels of methylation of Alu
and LINE-1 repetitive elements in the umbilical cord
blood leukocytes of their offspring [26]. It has been also
recently found using Illumina’s HumanMethylation450
BeadArray that fetal manganese exposure resulted in dif-
ferential methylation of several loci in the placenta includ-
ing those residing in fetal growth, neurodevelopmental,
and cancer-related genes [27].
Prenatal smoking
Maternal smoking throughout pregnancy and lactation
is one of the important factors determining the process
of developmental programming in modern societies. It
has been repeatedly shown to cause long-term adverse
health outcomes such as cognitive and behavioral im-
pairments, T2D, CVD, respiratory illness, and cancer in
offspring’s later life [28–30]. In several studies, epigen-
etic alterations such as changed DNA methylation and
dysregulated expression of miRNA have been demon-
strated to play an important role in mediating the link
between maternal cigarette smoking during pregnancy
and health outcomes throughout the life course [31].
Maternal smoking during pregnancy has been associated
with differential DNA methylation in neonates, par-
ticularly in gene growth factor independent 1 transcription
repressor (GFI1) implicated in diverse developmental pro-
cesses and genes aryl-hydrocarbon receptor repressor
(AHRR) and cytochrome P450 1A1 (CYP1A1) mediating
detoxification of the components of tobacco smoke [32].
In another MWAS for maternal smoking, several CpGs in
genes such as plasma membrane-associated class I myosin
(MYO1G) and neuronal transmembrane protein member
of the neurexin superfamily (CNTNAP2), associated with
cell elasticity and migration and brain development, re-
spectively, have been differentially methylated between the
adolescents prenatally exposed or unexposed to maternal
smoking [33]. In the replication cohort, the same CpGs
have been differentially methylated at birth, in childhood,
and throughout adolescence. Prenatal exposure to tobacco
products affected both global and gene-specific DNA
methylation in buccal cells of offspring during their child-
hood, and these effects have been modulated by variants
in detoxification genes [34]. Infants born to smokers had
higher levels of methylation at the differentially methylated
region (DMR) of the insulin-like growth factor 2 (IGF2)
gene in the umbilical cord blood compared to those born
to never smokers or to those who quit smoking during
pregnancy [35]. Prenatal smoke exposure also leads to a
persistent effect on DNA methylation levels, as measured
by repetitive element satellite 2 (Sat2), in adult peripheral
blood granulocytes [36]. Methylation changes in serial
blood samples at birth and at ages 7 and 17 years have
been related to the duration and intensity of the maternal
smoking during pregnancy [37]. In some CpG sites in genes
such as Kruppel-like factor 13 (KLF13), phospholipid-trans-
porting ATPase IIA (ATP9A), and GFI1, these alterations
have been reversible, whereas others (AHRR, MYO1G,
CYP1A1, and CNTNAP2) showed persistently distorted
methylation patterns. A comparison of patterns of off-
spring methylation and intensity of paternal and maternal
smoking demonstrated that association with maternal
smoking is much stronger than with a paternal one. The
role of epigenetic regulation in mediating long-lasting
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outcomes of maternal smoking has been observed in
studying genetic pathways, such as the brain-derived
neurotrophic factor (BDNF) pathway involved in brain de-
velopment, and associated with the development of cog-
nitive and affective dysfunctions. Higher rates of DNA
methylation have been observed in the BDNF-6 exon in
the blood of adolescent offspring of mothers who smoked
during pregnancy [38]. In utero exposure to smoking has
been linked to hypomethylation of the aryl hydrocarbon
receptor repressor (AHRR) gene in neonatal blood; further,
this association has been confirmed in other cell types
(buccal epithelium, cord blood mononuclear cells, and
placenta tissue) from newborn twins of mothers who
smoked during pregnancy [39]. Maternal smoking during
pregnancy has been also related to substantial changes in
DNA methylation at specific loci within the runt-related
transcription factor (RUNX3) gene, encoding a member of
the runt domain-containing family of transcription fac-
tors, in placental tissue [40]. The link between prenatal
smoke exposure and expression of miRNAs has been also
revealed. In the Maccani et al. study [41], maternal smok-
ing throughout pregnancy has been related to downregu-
lation of several miRNAs (miR-16, miR-21, and miR-146a)
implicated in growth and developmental processes. Col-
lectively, these findings suggest that maternal tobacco
smoking during pregnancy is substantially linked to
changed DNA methylation and dysregulated expression of
miRNAs, but a deeper understanding of how these epi-
genetic alterations can affect later health outcomes re-
mains to be elucidated [42, 43].
Evidence was also obtained suggesting that effects of
maternal marijuana smoking throughout pregnancy on
offspring’s health may be about the same as those of to-
bacco smoking [44]. A number of investigations have
linked prenatal cannabis exposure to an elevated rate of
intrauterine distress and growth retardation, as well as
to long-term behavioral impairments and increased risk
of adult neuropsychiatric disorders. These outcomes of
prenatal marijuana exposure are also assumed to be re-
lated to disrupted epigenetic regulation and associated
behavioral impairments [44]. Prenatal cannabis exposure
has been associated with decreased expression of dopa-
mine receptor D2 (DRD2) gene, which is a key element
in the brain circuit controlling motivation, in the ventral
striatum [45], as well as with impaired regulation of
opioid-related genes [46]. These findings demonstrate
that prenatal marijuana exposure causes differential
regulation of several candidate genes in distinct brain
circuits that may have long-term effects on cognitive
and emotional behaviors.
Prenatal alcohol exposure
Alcohol is a teratogen capable of inducing a wide range
of neurobehavioral and physical abnormalities. Evidence
from epidemiological studies suggest that in utero ex-
posure to alcohol can lead to a variety of detrimental
health outcomes (fetal alcohol spectrum disorders,
FASDs), including impaired neuroendocrine and behav-
ioral functioning, as well as mild cognitive impairments
in later life of offspring [47]. Ethanol has been found to
interfere with one-carbon metabolism and thereby with
DNA methylation level, suggesting the important role of
epigenetic mechanisms in the etiology of FASDs [47].
Moreover, alcohol is known to lead to a variety of nutri-
tional irregularities such as nutrient intake, utilization,
absorption, and excretion. Whereas some dietary com-
ponents can substantially affect gene expression, the nu-
trient imbalance induced by alcohol consumption can
also be the important contributor to distorted gene ex-
pression in FASD.
The role of epigenetic pathways in FASD develop-
ment is evident from numerous studies reporting vari-
ous fetal abnormalities and birth defects caused by
preconception alcohol consumption. It suggests that al-
cohol exposure may induce epigenetic changes in the
gametes, thereby causing the development of FASD-like
phenotypes [47]. A link between chronic alcohol use
and the hypomethylation of paternally imprinted loci,
H19 and IG-DMR, in sperm of male volunteers in gen-
omic regions critical for embryonic development has
been demonstrated [48].
Up to date, the epigenetic mechanisms of early life
programming of FASD have been investigated only in a
few epidemiological studies. In research by Wilhelm-
Benartzi et al., LINE-1 and AluYb8 methylation levels in
placental samples have been found to differ significantly
among those infants who have been prenatally exposed
to tobacco smoke and alcohol [49]. In a very recent 50 K
array-based DNA methylation analysis, several identical
changes in DNA methylation in the buccal epithelium of
six children with FASD have been obtained, primarily in
genes related to glutamatergic synapses, protocadherins
and hippo signaling [50].
A summary of epidemiological findings for a potential
epigenetic link between exposure to environmental xe-
nobiotics and later risk of chronic disease is presented in
Table 1.
Stress
Early life exposure to stressful life events is the im-
portant risk factor for developmental programming of
adverse health outcomes such as metabolic dysfunc-
tions [51], as well as behavioral and psychiatric condi-
tions such as anxiety, autism, and schizophrenia [52]
later in life. Increasing evidence from experimental,
clinical, and epidemiological studies highlight the im-
portance of epigenetic regulation in mediating these
long-term effects.
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Table 1 Summary of epidemiological findings for a potential epigenetic link between xenobiotic environmental exposures and chronic disease
Condition/exposure Stage Gene/element Epigenetic outcome Tissue/cells Age at detection Function/pathway Ref.
PAHs Prenatal ACSL3 Hypermethylation Umbilical cord leukocyte Neonate Asthma pathogenesis [6]
BPA Prenatal COMT, SULT2A1 Hypermethylation Liver Fetal Xenobiotic metabolism [11]
Prenatal MWAS Differential DNA methylation Placenta, kidney, liver Fetal Metabolism [12]




Periconception LINE-1 Hypomethylation Cord blood Adult Mutability [17]
Arsenic Early gestation MWAS Differential DNA methylation Cord blood Neonate Boys: carcinogenesis [20]
Prenatal MWAS Differential DNA methylation Cord blood Neonate Stress, apoptosis, inflammation [21]
Prenatal MWAS Differential DNA methylation Cord blood Neonate Binding sites of transcription
factors
[23]
Mercury Prenatal MWAS Differential DNA methylation Cord blood Neonate Immune system functions [14]
Prenatal MWAS Differential DNA methylation Placenta Neonate Neurobehavioral pathways [25]
Lead Prenatal Alu, LINE-1 Hypomethylation Umbilical cord leukocytes Neonate Mutability [26]
Manganese Fetal MWAS Differential DNA methylation Placenta Neonate Fetal growth, cancer,
neurodevelopment
[27]
Nicotine Prenatal AluYb8, LINE-1 Hypomethylation Buccal cells Infant Mutability [34]
Prenatal IGF2 Hypermethylation Umbilical cord blood Infant Growth, development [35]
Prenatal Sat2 Hypomethylation Peripheral blood granulocytes Adult Mutability [36]
Prenatal MWAS Differential DNA methylation Cord blood Neonate Development, detoxification [32]
Prenatal MYO1G CNTNAP2 Hypomethylation Hypermethylation Blood Adolescent Cell elasticity and migration
brain development
[33]
Prenatal BDNF-6 exon Hypermethylation Blood Adolescent Neuronal maturation [38]
Prenatal AHRR Hypomethylation Blood, placenta, peripheral blood
mononuclear cells, buccal epithelium
Neonatal Cell growth and differentiation [39]
Prenatal RUNX3 Differential methylation Placenta Neonatal Transcription factors [40]
Perinatal miR-16, miR-21,
miR-146a
Downregulation Placenta Neonate Growth and developmental processes [41]
Cannabis Prenatal DRD2 Downregulation Ventral striatum Fetal Dopamine receptor [45]
Prenatal Opioid-related genes Impaired regulation Distinct brain circuits Fetal Cognitive and emotional behaviors [46]
Alcohol Prenatal LINE-1, AluYb8 Differential methylation Placenta Neonatal Mutability [49]











Maternal stress and depression
Prenatal maternal stress has been repeatedly shown to
be associated with deregulation of the hypothalamo-
pituitary-adrenal (HPA) axis. In some studies, the crucial
role of the human glucocorticoid receptor gene (nuclear
receptor subfamily 3, group C, member 1, NR3C1) in
mediating that association has been highlighted.
Enhanced methylation in the CpG-rich region of the
promoter and exon 1F of the NR3C1 gene has been re-
vealed in the cord blood of neonates whose mothers
have been suffering from depression and anxiety during
the third trimester of their pregnancy and that effect
persisted through infancy up to 3 months of age [52].
Maternal depressive symptoms during pregnancy have
been strongly associated with enhanced levels of NR3C1
exon 1F methylation in male infants and decreased methy-
lation levels of the gene coding for another crucial factor
mediating these associations, BDNF IV, in both male and
female infants [53]. Maternal depression-associated chan-
ges in the levels of DNA methylation have been observed
in neonatal T lymphocytes; those alterations persisted to
adulthood in the hippocampal tissues [54].
Maternal psychological trauma during pregnancy also
may significantly influence the offspring epigenome.
Women’s experience of intimate partner violence during
pregnancy has been revealed to be related to NR3C1
methylation in whole-blood DNA of their adolescent off-
spring aged 10–19 [55]. Both the women exposed to the
Tutsi genocide during pregnancy and their children had
lower cortisol levels and higher methylation levels of the
NR3C1 exon 1F than non-exposed women and their off-
spring [56].
Early childhood adversity
Early postnatal period is also characterized by epigenetic
plasticity. The epigenetic link between adversity in early
childhood caused by exposure to emotional/psychological,
sexual, and physical abuse, maltreatment, poor quality
parenting or loss of parents, etc. and later-life health out-
comes has been demonstrated repeatedly.
In several studies, low socioeconomic status (SES) has
been used as an indicator for stressful conditions early in
life. The low SES conditions have been found to be
strongly associated with psycho-emotional disorders in
adult life, such as schizophrenia and depression [57], as
well as CVD and metabolic disorders [58]. Disadvantaged
SES early in life has been related to altered whole-genome
methylation profiles in blood DNA [59]. Functionally,
most genes differentially methylated in association with
low early life SES have been involved in various cell signal-
ing and metabolic pathways. In another genome-wide
transcriptional profiling, low-SES background in early life
has been associated with significant upregulation of genes
bearing response elements for the cAMP response
element binding protein/activating transcription factor
(CREB/ATF) family of transcription factors that conveys
the adrenergic signals to leukocytes, in saliva of healthy
adults [60]. Genes with response elements for glucocortic-
oid receptor, regulating the secretion of cortisol and trans-
ducing its anti-inflammatory actions in the immune
system, were significantly down-regulated.
Moreover, those individuals who had low SES in early life
also exhibited enhanced daily life cortisol secretion along
with increased expression of transcript-bearing response
elements for nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-κB) and elevated stimulated produc-
tion of the pro-inflammatory cytokine IL-6. Deleterious
consequences of low SES in early life on immune func-
tions and inflammatory processes in adulthood have been
shown to be buffered by high maternal warmth, and these
changes have been accompanied by modulating the
genome-wide transcriptional profile [61]. Low early life
SES subjects whose mothers exhibited a high level of
warmth toward them demonstrated reduced Toll-like
receptor-stimulated production of interleukin 6 and de-
creased activity of both immune activating transcription
factor (AP-1) and pro-inflammatory transcription factor
NF-κB in adulthood compared to individuals who had low
SES early in life but experienced low levels of maternal
warmth.
In a genome-wide research of the long-lasting effects of
unfavorable experiences such as physical and sexual abuse
or neglect early in life, 362 differentially methylated pro-
moters have been found in hippocampal neurons derived
from the postmortem brain tissues of individuals with a
history of severe childhood abuse relative to control sub-
jects [62]. Genes implicated in cellular/neuronal plasticity
have been most differentially methylated among abused
and non-abused subjects. In another MWAS, promoters
of 997 genes implicated in key cell signaling pathways re-
lated to control of transcription and development have
been differentially methylated in the whole blood of adult
individuals in association with their childhood abuse [63].
In a genome-wide promoter DNA methylation analysis
performed in T cells from adult men, 448 gene promoters
have been differentially methylated in subjects with a
history of chronic physical aggression from 6 to 15 years
of age relative to the control group [64]. Most of these
genes are known to play an important role in aggressive
behavior.
In the study by McGowan et al. [65], significant hyper-
methylation in the promoter and 5′ regulatory region of
ribosomal RNA (rRNA) gene in the brain of suicidal in-
dividuals with history of early childhood neglect/abuse,
consistent with decreased rRNA expression levels in the
hippocampus, has been indicated relative to the control
subjects. In the subsequent study, substantially reduced
expression of NR3C1 1F has been revealed in suicide
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victims with a history of childhood abuse compared to
non-abused suicide victims or control individuals; no
difference, however, has been demonstrated between
non-abused suicide victims and controls [66]. Childhood-
abuse-associated decrease in NR3C1 expression has been
related to elevated methylation in the NR3C1 1F promoter
in the hippocampus of suicide completers relative to both
suicide completers with no history of abuse and control
individuals [67]. Enhanced methylation of the exon
NR3C1 1F promoter has been also found in the peripheral
blood of persons with major depressive disorder and bor-
derline personality disorder as a result of childhood mal-
treatment [68]. Differential DNA methylation patterns
were indicated in buccal epithelium of adolescents whose
parents reported high levels of stress throughout their
early childhood [69]. Differential patterns of the whole-
genome DNA methylation in blood samples have been
evident among institutionalized children and infants
raised by their own biological parents [70]. Most of differ-
entially methylated genes have been either contributed to
cell signaling pathways or to immune function, including
those involved in brain development and functioning and
in neural communication. One hundred seventy-three
differentially methylated genes mainly implicated in
inflammatory/immune responses, in several important
cellular processes, and in the pathways of antigen process-
ing and presentation, have been identified among individ-
uals with and without previous placement into foster care
[71]. A strong association has been observed between the
mothers’ reports on the parenting quality provided to their
children and the offspring’s methylation levels of the
NR3C1 gene and the macrophage migration inhibitory
factor (MIF) gene involved in NR3C1 expression and im-
mune responses in blood samples 5 to 10 years after the
assessing the caregiving quality [71]. Childhood adversity,
as measured by childhood maltreatment, parental loss, and
parental care, has been also linked to impaired cortisol re-
sponse to stress, as well as to enhanced NR3C1 promoter
methylation in leukocyte DNA from healthy adults [72].
Overall, these data provide new insight into the
mechanisms underlying early stress-induced deterior-
ation of pathways implicated in stress reactivity and
social behavior. It is assumed that early the stress-
induced change of expression of the NR3C1 gene may
change the cortisol activity, thereby disturbing neuro-
endocrine control and impairing behavior and cogni-
tion in adulthood. There is also some evidence that
unfavorable modification of epigenetic regulation trig-
gered by stressful conditions in early life can be partly
abolished via favorable psychological climate in subse-
quent life [61].
Table 2 summarizes epidemiological findings for a po-
tential epigenetic link between exposure to stressful con-
ditions in early life and later disease.
Malnutrition
Substantial research findings support the idea that inad-
equate nutrition early in life can be a risk factor for a
variety of human diseases [73]. Important evidence for
the relationship between early nutrition and adult health
status comes from natural experiments, i.e., naturally oc-
curring circumstances in which different subpopulations
have different levels of exposure to supposed causal fac-
tors. Adverse long-term health outcomes have been re-
peatedly observed in birth cohorts exposed to famine in
early life. Most well known in this aspect is research of
the Dutch famine of 1944–1945. Early life undernutri-
tion during this famine led to various adult metabolic
and mental consequences including atherogenic plasma
lipid profile, obesity, and CVD, as well as depression and
schizophrenia [74–76]. In several studies, epigenetic dif-
ferences associated with prenatal exposure to the Dutch
famine have been observed. Heijmans et al. [77] identi-
fied the methylation patterns in the whole blood of sib-
lings who have been either exposed or not exposed to
the Dutch famine throughout gestation. In adult persons
aged 60+, periconceptional famine exposure has been as-
sociated with decreased methylation of the IGF2 gene
involved in growth and development, in exposed com-
pared to non-exposed siblings. In a subsequent study
within the same cohort, some other genes implicated in
growth and metabolic disorders, such as ATP-binding
cassette transporter 1 (ABCA1), paternally expressed
antisense transcript of the G-protein alpha subunit com-
plex locus (GNASAS), insulin/insulin-like growth factor
(INSIGF), interleukin 10 (IL10), leptin (LEP), and mater-
nally expressed gene 3 (MEG3), had differential levels of
DNA methylation in exposed and unexposed siblings
[78]. Recently, in a MWAS conducted in the Dutch fam-
ine cohort, changes in adult whole-blood DNA methyla-
tion in persons who have been exposed to famine
prenatally compared to unexposed control subjects have
been revealed [79]. Early gestation, but not mid- or late
gestation, has been identified as a critical period for
these alterations, mostly related to genes implicated in
growth, development, and metabolism. A genome-scale
analysis of differential DNA methylation in the whole
blood after exposure to the Dutch famine in early life re-
vealed that prenatal malnutrition-associated differentially
methylated regions (P-DMRs) occur preferentially at
regulatory loci and map to genes enriched for differential
expression throughout early development [80]. Differen-
tial methylation of the P-DMRs extends along pathways
related to growth and metabolism, so the authors con-
cluded that epigenetic disturbances in these pathways
caused by prenatal malnutrition can provoke or exacer-
bate impaired metabolic phenotype later in life. To-
gether, these data indicate that effects of prenatal famine
depend on the period of exposure, with early gestation
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appearing to be a critical period. Since the epigenome is
most sensitive to environmental cues throughout this de-
velopmental stage [3], these findings are indicative of a
role of epigenetic processes in driving long-term outcomes
of early life famine exposure. Epidemiological evidence for
a causal association between prenatal malnutrition and
adult disease is presented in Table 3.
Conclusions
There is increasing evidence that many human chronic dis-
orders originate in early life, and epigenetic mechanisms
play a key role in mediating these effects. Several genes
have been identified as key candidate genes underlying
developmental programming of particular diseases. In-
corporating these novel ideas on the mechanisms of devel-
opmental epigenetic programming into the mainstream of
current beliefs regarding the causation of pathological
processes would certainly shift the focus of efforts targeted
at preventing chronic diseases from late stages to very
early stages of human life from periconception to weaning.
Functional characterization of genetic pathways that are
epigenetically labile in response to specific environmental
Table 2 Summary of epidemiological findings for a potential epigenetic link between early life stressful conditions and disease in
later life
Condition/exposure Stage Gene/element Epigenetic outcome Tissue/cells Age at detection Function/pathway Ref.
Maternal depression Prenatal NR3C1 1F Hypermethylation Blood Neonate, infant Stress reactivity [52,
53]
Prenatal BDNF IV Hypomethylation Blood Infant Neuronal maturation [53]




Neonate, adult Immune system
functions
[54]
Low SES Childhood MWAS Differential DNA
methylation



















Childhood MWAS Differential DNA
methylation
Blood Adult Development, regulation
of transcription
[63]
Childhood MWAS Differential DNA
methylation
T lymphocytes Adult Aggressive behavior [64]















Childhood NR3C1 1F Hypermethylation Peripheral blood Adult Stress reactivity [68]
Childhood MWAS Differential DNA
methylation
T cells 7–14 years Inflammatory/immune
responses
[71]
Childhood NR3C1 Hypermethylation Blood 5–10 years Stress reactivity [71]
Childhood NR3C1 promoter Hypermethylation Leukocytes Adult Stress reactivity [72]
Table 3 Epidemiological evidence for a causal association between prenatal malnutrition and adult disease
Condition/exposure Stage Gene/element Epigenetic outcome Tissue/cells Age at detection Function/pathway Ref.
Famine Periconceptional IGF2 Hypomethylation Blood 60+ Growth, development [77]
Periconceptional IL10, LEP, MEG, ABCA1,
GNASAS;
INSIGF




Early gestation MWAS Differential DNA
methylation
Blood Adult Growth, development,
metabolism
[79]
Periconceptional P-DMRs Differential DNA
methylation
Blood Adult Growth, metabolism [80]
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cues further highlights the epigenetic mechanisms me-
diating the development and progression of adult-life
pathologies.
Since epigenetic marks are potentially reversible, a dee-
per understanding of mechanisms implicated in long-term
effects of early life adverse experiences will likely result in
the development of new effective therapeutic options tar-
geted to the removal of the inappropriate epigenetic
marks. Current epigenetic pharmacological therapies pro-
vide clinical benefits through inhibiting DNA methyltrans-
ferases (DNMTs) or histone deacetylases (HDACs). Three
HDAC inhibitors, namely, Zolinza (Vorinostat), Istodax
(Romidepsin), and Beleodaq (Belinostat), as well as two
DNMT inhibitors, Vidaza (5-Azacytidine) and Dacogen
(Decitabine), are approved by the FDA to date [81]. Sev-
eral other HDAC and DNMT inhibitors are now in devel-
opment. Other promising players include non-coding
RNAs such as miRNAs and long RNAs that also are
known to be important modifiers of the epigenome.
Although some concerns are raised because these drug
candidates are unspecific and, therefore, can lead to large-
scale epigenetic deregulation, there is hope that in the
future more effective therapies will be developed targeting
only particular epigenomic elements. Thereafter, the
epigenome-targeted pharmacological therapy may likely
become a powerful tool in clinical practice. Furthermore,
since the early life deleterious epigenetic programming
can be reversed, at least partly, by favorable psycho-social
conditions later in life [61], use of self-soothing tech-
niques, such as meditation, may be another promising
therapeutic approach. Such a possibility is evident from a
recent study by Kaliman et al. [82], where intensive prac-
tice of mindfulness meditation resulted in alterations of
histones H4ac and H3K4me3, as well as in decreased ex-
pression of histone deacetylase genes (HDAC 2, 3, and 9)
and pro-inflammatory genes (RIPK2 and COX2) in medita-
tors compared to control individuals. If it is possible to cor-
rect disrupted epigenetic patterns via specific epigenome-
targeted therapeutic interventions, then it will be possible
to prevent a variety of chronic diseases to extend the
human health span.
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